De.Mem Limited
DEM.ASXUtilities
Commercializing innovative products and technologies for decentralized water and waste water treatment.
Market Data
$0.069
+0.0%$21.6M
-100000.0x
$-0.007
0.00%
-0.3%
Latest Earnings
DEM Record Full Year Results
27 February 2026
De.mem Limited (ASX:DEM) delivered record full-year CY2025 results, with revenue up 20% to $29.9m and gross margins expanding to a record 43%, alongside its first full calendar year of positive adjusted EBITDA at $1.6m (vs -$60k in CY2024). The company achieved 27 consecutive quarters of cash receipts growth and maintained a strong balance sheet with $4.0m in cash. Management guided for another record year in CY2026, underpinned by a full-year contribution from the recently acquired Core Chemicals and continued organic growth momentum. Key points: Record revenue of $29.9m, up 20% vs prior corresponding period (pcp).; Record adjusted EBITDA of $1.6m — first full calendar year of positive adjusted EBITDA, a major inflection from -$60k in CY2024.; Record gross margins of 43%, up from 41% in CY2024, continuing a long-term progression from 18% in 2017.
Recent Announcements
DEM Investor Presentation - Full Year Results
De.mem Limited (ASX:DEM) presented full-year 2025 results showing record achievements: $32.3m in cash receipts (+24% CAGR over 6.75 years), positive operating cash flow of $318k, and adjusted EBITDA of $1.6m, with the company leveraging its decentralized water treatment technology and 90%+ recurring revenue model to target record 2026 results supported by the Core Chemicals acquisition and domestic water product rollout.
DEM Record Full Year Results
De.mem Limited (ASX:DEM) delivered record full-year CY2025 results, with revenue up 20% to $29.9m and gross margins expanding to a record 43%, alongside its first full calendar year of positive adjusted EBITDA at $1.6m (vs -$60k in CY2024). The company achieved 27 consecutive quarters of cash receipts growth and maintained a strong balance sheet with $4.0m in cash. Management guided for another record year in CY2026, underpinned by a full-year contribution from the recently acquired Core Chemicals and continued organic growth momentum. Key points: Record revenue of $29.9m, up 20% vs prior corresponding period (pcp).; Record adjusted EBITDA of $1.6m — first full calendar year of positive adjusted EBITDA, a major inflection from -$60k in CY2024.; Record gross margins of 43%, up from 41% in CY2024, continuing a long-term progression from 18% in 2017.
2025 Appendix 4E and Annual Report
De.mem Limited (ASX:DEM) delivered strong FY2025 results with revenue up 20% to $29.9M and gross margins expanding to 43% (from 41%), driven by its high-margin specialty chemicals and recurring services businesses. The company achieved its first full financial year of positive Adjusted EBITDA at $1.6M (vs -$0.06M in FY2024), while net loss narrowed 26.9% to $2.03M. No dividend was declared, but the company ended the year with $4.0M in cash and an improved balance sheet, with the recent Core Chemicals acquisition expected to further boost revenues in FY2026. Key points: Revenue grew 20% to $29.9M (FY2024: $24.9M), with 27 consecutive quarters of cash receipts growth vs prior corresponding period; First full financial year of positive Adjusted EBITDA at $1.564M, a turnaround from -$0.06M in FY2024 and a multi-year improving trend; Gross margin expanded to 43% (FY2024: 41%; FY2023: 36%), with absolute gross profit up 25% to $12.7M, reflecting successful transition to high-margin recurring revenue
Get real-time alerts for DEM
Receive AI-powered earnings summaries and instant notifications when De.Mem Limited releases results.
Register Free